Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$150.19 - $173.5 $13.1 Million - $15.2 Million
-87,500 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$140.71 - $165.05 $4.22 Million - $4.95 Million
30,000 Added 52.17%
87,500 $14.4 Million
Q3 2020

Nov 16, 2020

BUY
$105.46 - $144.13 $6.06 Million - $8.29 Million
57,500 New
57,500 $8.2 Million
Q3 2018

Nov 14, 2018

SELL
$161.01 - $180.57 $15.8 Million - $17.7 Million
-98,000 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$146.33 - $183.18 $3.76 Million - $4.71 Million
-25,700 Reduced 20.78%
98,000 $16.9 Million
Q3 2017

Nov 14, 2017

BUY
$142.62 - $155.6 $17.6 Million - $19.2 Million
123,700
123,700 $18.1 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.54B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.